GlassScriptPhysician profile
Richard Lee Overmeyer
NPI 1023084142
$3,581.67
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,061 · 2020: $772 · 2021: $1,330 · 2022: $419.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $728.22 | 2019-2022 | |
| Amgen INC. | $415.50 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $292.45 | 2019-2022 | |
| Abbvie INC. | $289.09 | 2020-2021 | |
| Pfizer INC. | $213.03 | 2019-2021 | |
| Lilly USA, LLC | $158.31 | 2019-2022 | |
| Esperion Therapeutics, INC. | $145.92 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.17 | 2019-2022 | |
| Allergan, INC. | $128.07 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $123.45 | 2020-2022 | |
| Amarin Pharma, INC. | $122.07 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $95.19 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $94.69 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $83.31 | 2019-2022 | |
| Glaxosmithkline, LLC. | $74.66 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $61.77 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.02 | 2020-2021 | |
| Abbott Laboratories | $49.90 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $35.47 | 2020-2021 | |
| Astellas Pharma US INC | $28.88 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $28.82 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $27.77 | 2021 | |
| Radius Health, INC. | $26.35 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $24.51 | 2021-2022 | |
| Medtronic, INC. | $21.86 | 2021 | |
| Boston Scientific Corporation | $16.28 | 2022 | |
| Nestle Healthcare Nutrition INC. | $15.27 | 2021 | |
| Endo Pharmaceuticals INC. | $15.18 | 2022 | |
| Arbor Pharmaceuticals, INC. | $14.33 | 2019 | |
| Shire North American Group INC | $14.00 | 2019 | |
| Atricure, INC. | $13.42 | 2022 | |
| Currax Pharmaceuticals LLC | $13.38 | 2022 | |
| Genentech USA, INC. | $11.33 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Overmeyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.